Lagoons are the most popular wastewater treatment technology in Canada with hundreds of installations across the country. Most of these systems will require upgrades in order to increase their treatment capacity or to comply with new regulations such as the Wastewater Systems Effluent Regulations registered by the Government of Canada. Bionest is developing at the present time the BIONEST KAMAKTM technology to enhance lagoon capacity.
Raglan Mine is developing new, strategic and aligned approaches to its Community Social Involvement (CSI) program. The aim of this program is to partner with others to deliver long lasting value through programs of capacity building, and community social and economic development. This proposed research project involves further developing a comprehensive Community Social Involvement (CSI) model that responds to the needs and desires of both Raglan Mine and the villages of Nunavik.
Teams in crisis management operate in uncertainty and time pressure conditions, which severely constrain team performance. Systems capable of detecting critical levels of cognitive functioning could help teams to adapt better to the situation they face by allowing an intelligent re-allocation of tasks across agents. Traditionally, adaptive systems are based on the operator behavioral response (such as performance).
Le projet consiste à créer un modèle 3D interactif du monastère des Ursulines de Québec pour une diffusion Web afin de mettre en valeur l’héritage des religieuses ainsi que son monastère (considéré comme un bien patrimonial national). Notre projet est avant-gardiste parce qu’il propose une libre navigation dans le modèle aux internautes. En effet, la reconstitution est construite sur une plate-forme jeu (gaming engine) permettant une meilleure fluidité et interactivité, tout en respectant l’authenticité des lieux réels.
We will assess the quality and suitability of blood and blood-derived products using a fast and economical approach that combines measurements of molecules in the blood product identified by their weight and computational approaches to make sense of all the data generated. Normal blood products have thousands of small molecules in common. By monitoring a large spectrum of these molecules, we will be in a position to determine the normal state and the quality of the products.
Ce projet porte sur l’évaluation de la performance de gestionnaires de fonds de placement. Plus spécifiquement, dans ce projet on cherche à développer des outils qui permettront à la compagnie de déterminer, à partir de données sur ses rendements passés et sur le rendement d’indices de marché appropriés, si un gestionnaire d’actif a été significativement plus performant dans ses placements que l’indice de marché en question.
Bombardier Aerospace, Bell Helicopter Textron Canada Limited and Pratt & Whitney Canada have all initiated projects on Additive Manufacturing processes. Although applications are different, all companies are facing the same challenges including the lack of a mature certification path and a mature Canadian supply chain. In order to accelerate the maturation of this technology, we are proposing the first Canadian industryled R&D program on additive manufacturing (AM).
The proposed project is to develop a bioaerosol sampler which will have minimal impact on the infectivity of captured viruses. Airborne viruses are subjected to environmental conditions which could affect their potential of infectivity as well as their capacity to resist the shearing forces and desiccating conditions during sampling procedures with standard sampling apparatuses. This leads to the underestimation of infective viral loads in aerosols and could have a dramatic impact on the nature of the decisions taken for aerosol contamination control.
Can you tell us a bit about the research you did through Mitacs Accelerate that led to you winning the Mitacs Award for Outstanding Innovation – Post Doctoral?
Prostate cancer is the more common cancer affected men in developed countries. Epidemiological data suggest that omega-3 fatty acids may prevent prostate cancer initiation and progression. However, these data do not decipher which omega-3 fatty acid presents the more potent anticancer properties. SCF Pharma has developed pure and highly bioavailable omega-3 fatty acids monoglycerides. Interestingly, data from SCF Pharma showed that these pure monoglycerides form of fatty acids can reduce the growth and the proliferation rate of prostate cancer cells in culture.